Oragenics Inc. · LSE:0A64

Oragenics Inc. financial statements

Oragenics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue0037.7K131.5K87.0K00000
Cost of revenue4.11M15.5M44.7K41.2K22.1M62.6K30.1K00
Gross profit-4.11M-27.4K86.9K45.8K-22.1M-62.6K-30.1K00
Research and development2.39M4.11M15.5M10.1M10.6M22.1M12.1M5.97M3.54M4.75M
Selling, general and administrative6.97M6.44M5.45M4.48M5.27M4.53M3.76M4.02M3.18M3.79M
Operating income-9.36M-10.6M-20.9M-14.4M-15.8M-26.6M-15.9M-9.99M-6.72M-8.54M
Depreciation and amortization771.4M027.4K44.7K41.2K51.7K62.6K30.1K65.8K75.0K
EBITDA762.1M-10.6M-20.9M-14.4M-15.7M-26.6M-15.8M-9.96M-6.65M-8.47M
Interest expense785.9K29.8K30.6K15.1K15.8K10.7K7.30K5.79K216.3K4.12K
Income before tax-9.98M-10.6M-20.7M-14.3M-15.7M-26.4M-15.6M-9.91M-6.73M-8.50M
Income tax-136.9K-1-127.0K16.4K12.5K7.76K000
Net income-9.84M-10.6M-20.7M-14.3M-15.7M-26.4M-15.6M-9.91M-6.73M-7.01M
Earnings per share, basic-4.56-47.88-9.18-7.11-8.09-0.47-0.37-0.87-1.37-1.57
Earnings per share, diluted-4.56-47.88-9.18-7.11-0.14-0.47-0.37-0.87-1.37-1.57

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents4.40M864.8K3.48M11.4M27.3M17.6M18.3M20.2M6.17M4.08M
Short-term investments4.00M017.9K00
Receivables53.1K6.99K6.99K0
Inventory00
Current assets10.1M1.47M3.87M14.3M27.7M18.0M18.8M21.9M7.19M4.22M
Property, plant and equipment0121.1K45.7K42.7K92.0K116.3K21.7K87.5K
Goodwill00
Total assets10.1M1.47M4.97M14.8M28.2M18.7M19.8M22.0M7.21M4.31M
Accounts payable1.56M1.14M1.24M246.7K855.0K330.4K1.21M828.7K618.4K461.3K
Current liabilities1.79M1.68M1.80M1.60M1.45M1.34M1.85M1.17M898.5K1.34M
Long-term debt00
Total debt227.3K328.5K322.5K624.5K797.2K898.9K979.6K124.2K80.5K66.4K
Total liabilities1.79M1.68M1.80M1.75M1.74M1.84M2.52M1.17M898.5K1.34M
Shareholders' equity8.28M-211.9K3.17M13.0M26.5M16.8M17.2M20.9M6.32M2.97M
Shares outstanding4.27M419.0K3.08M2.02M2.00M91.8M46.1M29.4M4.93M4.91M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-9.25M-8.60M-7.29M-15.2M-13.5M-17.0M-13.0M-9.08M-6.36M-7.08M
Capital spending-30-1.00M-127.5K-43.9K-43.9K-25.2K-124.7K-124.7K-27.2K
Free cash flow-9.25M-8.60M-8.29M-15.4M-13.5M-17.0M-13.0M-9.20M-6.36M-7.10M
Cash from investing-936.3K-115.5K-43.9K-43.9K-25.2K-124.7K-124.7K1.68M
Cash from financing16.8M5.98M283.9K-494.9K23.1M16.3M11.1M23.2M8.45M4.45M
Dividends paid-1.12M-1.12M-661.5K-413.2K-58.7K00
Share buybacks-5.64M-5.64M661.5K252.9K58.7K6.18M2.64M
Change in cash7.53M-2.62M-7.94M-15.8M9.63M-628.4K-1.94M14.0M2.09M-948.6K